Chris Stauffer, MD is dual board-certified in Psychiatry and Addiction Medicine. He is Assistant Professor of Psychiatry at the Oregon Health & Science University (OHSU) and Physician Scientist at the Portland VA Medical Center. He attended medical school at OHSU, Adult Psychiatry Residency at the University of California, San Francisco (UCSF), and completed an Advanced Neuroscience Research Fellowship at the San Francisco VA. He is currently the recipient of a Veterans Affairs Clinical Science Career Development Award.
Dr. Stauffer practices general psychopharmacology for a wide range of psychiatric disorders. He specializes in the treatment of PTSD and substance use disorders in both Veterans and LGBTQI+ populations. He has experience working in opioid treatment programs through the VA and at the San Francisco General Hospital and is certified to prescribe buprenorphine. He is also certified by the Multidisciplinary Association of Psychedelic Studies (MAPS) to conduct MDMA-assisted psychotherapy for PTSD in FDA-approved contexts.
Dr. Stauffer combines social psychopharmacology - such as oxytocin, MDMA, and psilocybin - with psychotherapy to treat psychiatric disorders. He is Principal Investigator of a VA-sponsored 6-week clinical trial of intranasal oxytocin for co-occurring opioid and stimulant use disorder (NCT03016598) and a clinical trial of oxytocin-enhanced motivational interviewing group therapy for methamphetamine-using men who have sex with men (NCT02881177). Other relevant research roles have included: Sub-Investigator, Study Physician, and Study Therapist at the UCSF site for MAPS-sponsored Phase 2 (NCT03282123) and Phase 3 (NCT03537014) trials of MDMA-assisted psychotherapy for PTSD and Co-Investigator and Study Therapist for a trial of psilocybin-assisted group therapy for demoralization in longterm AIDS survivors (NCT02950467). He is Co-PI of the Somatic Center Portland Expanded Access site for MDMA-assisted psychotherapy for PTSD. Dr. Stauffer has a particular interest in exploring psychedelic medicines in combination with group therapy and in ensuring accessibility for marginalized communities. He is on the Editorial Board of the Journal of Psychoactive Drugs.
Dr. Stauffer has formally taught courses in psychedelic medicine, attachment theory, and substance use disorders to medical students and mental health trainees. He is a Course Contributor for "Foundations in MDMA and Psilocybin Safety, Therapeutic Applications & Research" with Psychedelic.Support. He is currently co-leading the OHSU Psychedelic Medicine Research Collaborative, teaches Ketamine Assisted Psychotherapy with Polaris Insight Center, and is a mentor for the Center for Psychedelic Therapies and Research certificate program at the California Institute of Integral Studies.